BioVie Inc.
- BIVI
- NASDAQ
- Biotechnology
- Clinical-Stage Biotech
$1.20
Today +6.19%Quote Oct 16, 2026, 08:00 PM UTC
−32.58%over the last month
Max drawdown −36.5%From 1-month high −32.6%3 months −16.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$9.1M
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.17
2.9% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BIVIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
13